Granted Patent
B2
US 8,044,195 · App. 12/759,073 · Granted Oct 25, 2011
Cross-linked glycopeptide-cephalosporin antibiotics
Assignee:
Theravance, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Abstract
This invention provides cross-linked glycopeptide—cephalosporin compounds and pharmaceutically acceptable salts thereof which are useful as antibiotics. This invention also provides pharmaceutical compositions containing such compounds; methods for treating bacterial infections in a mammal using such compounds; and processes and intermediates useful for preparing such compounds.
Claims (4)
1. A compound of the formula:
or a pharmaceutically-acceptable salt thereof.
2. A pharmaceutical composition comprising a pharmaceutically-acceptable carrier and a compound of the formula:
or a pharmaceutically acceptable salt thereof.
Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jun 10, 2014
From: THERAVANCE, INC.
To: THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC
Reel/Frame 033179/0484 →
Continuity (5)
Provisional Application
60328889
· Oct 12, 2001